Elevance Health (Elevance Health) 12-1 Month Momentum %

: 14.00% (As of Today)

View and export this data going back to 2001. Start your Free Trial

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-24), Elevance Health's 12-1 Month Momentum % is 14.00%.

The industry rank for Elevance Health's 12-1 Month Momentum % or its related term are showing as below:

ELV's 12-1 Month Momentum % is ranked better than
68.42% of 19 companies
in the Healthcare Plans industry
Industry Median: -0.92 vs ELV: 14.00

Competitive Comparison

For the Healthcare Plans subindustry, Elevance Health's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elevance Health 12-1 Month Momentum % Distribution

For the Healthcare Plans industry and Healthcare sector, Elevance Health's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Elevance Health's 12-1 Month Momentum % falls into.

Elevance Health (NYSE:ELV) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health (NYSE:ELV) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Elevance Health 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Elevance Health's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elevance Health (Elevance Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (NYSE:ELV) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

ELV:Mexico A58:Germany A58:Germany

Address

220 Virginia Avenue, Indianapolis, IN, USA, 46204

Website

https://www.elevancehealth.com

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Executives

Blair Williams Todt	officer: EVP and Chief Legal Officer	8735 HENDERSON ROAD, TAMPA FL 33625
Ronald W Penczek	officer: SVP, Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Mark Kaye	officer: EVP & CFO Designate	7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007
Dixon Robert L Jr	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gloria M Mccarthy	officer: EVP, Office of the CEO	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Kendrick Charles Morgan Jr	officer: EVP & President, Commercial	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Deanna D Strable-soethout	director	C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392
Ramiro G Peru	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260
Peter D Haytaian	officer: EVP & Pres., Govt. Bus. Div.	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Susan D. Devore	director	C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Ryan M. Schneider	director	1680 CAPITAL ONE DRIVE, MCLEAN VA 22102
John E Gallina	officer: SVP & Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Julie A Hill	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Thomas C Zielinski	officer: EVP & General Counsel
Jeffrey D. Alter	officer: EVP, IngenioRx & Anthem Health	4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122